EcoDrugPlus

Solute Carrier Family 6 Member 3

Ensembl ID : ENSBMUG00000019851
Gene Symbol: SLC6A3
1 Cross references
166 Possible Orthologues:

Solute Carrier Family 6 Member 4

Ensembl ID : ENSBMUG00000009114
Gene Symbol: SLC6A4
3 Cross references
205 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSBMUG00000003021
Gene Symbol: SLC6A9
2 Cross references
200 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSBMUG00000012857
Gene Symbol: SLC9A3
3 Cross references
238 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSBMUG00000016112
Gene Symbol: SSTR1
1 Cross references
160 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSBMUG00000002938
Gene Symbol: SSTR2
3 Cross references
264 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSBMUG00000024684
Gene Symbol: SSTR3
3 Cross references
251 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSBMUG00000023573
Gene Symbol: SSTR5
3 Cross references
257 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSBMUG00000016308
Gene Symbol: SPHK2
3 Cross references
209 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSBMUG00000013456
Gene Symbol: S1PR1
3 Cross references
194 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSBMUG00000009998
Gene Symbol: SYK
3 Cross references
203 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSBMUG00000001210
Gene Symbol: LOC102270241
2 Cross references
206 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).